Hydroxypyridinone-Diamine Hybrids as Potential Neuroprotective Agents in the PC12 Cell-Line Model of Alzheimer's Disease
There is an urgent need to propose effective treatments for Alzheimer’s disease (AD). Although the origin of the disease is poorly understood, several therapeutic options have been proposed. The new therapeutic approaches targeting biometal-mediated neurodegenerative pathways appear to be interestin...
Saved in:
Main Authors: | Elodie Lohou (Author), N. André Sasaki (Author), Agnès Boullier (Author), Marine Duplantier (Author), Pascal Sonnet (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2019-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quorum Sensing Inhibitors to Quench <i>P. aeruginosa</i> Pathogenicity
by: Marine Duplantier, et al.
Published: (2021) -
Discovery of benzamide-hydroxypyridinone hybrids as potent multi-targeting agents for the treatment of Alzheimer's disease
by: Xiaoying Jiang, et al.
Published: (2021) -
Indazole-Quinolone Hybrids as Anti-Virulence Agents against <i>Pseudomonas aeruginosa</i>
by: Marie Hanot, et al.
Published: (2024) -
Functionality study of chalcone-hydroxypyridinone hybrids as tyrosinase inhibitors and influence on anti-tyrosinase activity
by: L. Ravithej Singh, et al.
Published: (2020) -
Synthesis and antileishmanial activity of antimony (V) complexes of hydroxypyranone and hydroxypyridinone ligands
by: Vafa Sheikhmoradi, et al.
Published: (2018)